Madan Jagasia
Faculty Member
Last active: 3/20/2014


Clinical trials in GVHD, new drugs in leukemia, lymphoma and myeloma. Novel preparative regimen for stem cell transplant.


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival. McClune BL, Ahn KW, Wang HL, Antin JH, Artz AS, Cahn JY, Deol A, Freytes CO, Hamadani M, Holmberg LA, Jagasia MH, Jakubowski AA, Kharfan-Dabaja MA, Lazarus HM, Miller AM, Olsson R, Pedersen TL, Pidala J, Pulsipher MA, Rowe JM, Saber W, van Besien KW, Waller EK, Aljurf MD, Akpek G, Bacher U, Chao NJ, Chen YB, Cooper BW, Dehn J, de Lima MJ, Hsu JW, Lewis ID, Marks DI, McGuirk J, Cairo MS, Schouten HC, Szer J, Ramanathan M, Savani BN, Seftel M, Socie G, Vij R, Warlick ED, Weisdorf DJ (2014) Biol Blood Marrow Transplant 20(7): 960-8
    › Primary publication · 24641829 (PubMed) · PMC4057955 (PubMed Central)
  2. Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis. Sengsayadeth S, Wang T, Lee SJ, Haagenson MD, Spellman S, Fernandez Viña MA, Muller CR, Verneris MR, Savani BN, Jagasia M (2014) Biol Blood Marrow Transplant 20(6): 900-3
    › Primary publication · 24631737 (PubMed) · PMC4034271 (PubMed Central)
  3. Increased BCR responsiveness in B cells from patients with chronic GVHD. Allen JL, Tata PV, Fore MS, Wooten J, Rudra S, Deal AM, Sharf A, Hoffert T, Roehrs PA, Shea TC, Serody JS, Richards KL, Jagasia M, Lee SJ, Rizzieri D, Horwitz ME, Chao NJ, Sarantopoulos S (2014) Blood 123(13): 2108-15
    › Primary publication · 24532806 (PubMed) · PMC3968393 (PubMed Central)
  4. Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues. Goswami M, Hensel N, Smith BD, Prince GT, Qin L, Levitsky HI, Strickland SA, Jagasia M, Savani BN, Fraser JW, Sadrzadeh H, Rajkhowa T, Ito S, Jain NA, Battiwalla M, Fathi AT, Levis MJ, Barrett AJ, Hourigan CS (2014) Leukemia 28(5): 1167-70
    › Primary publication · 24472813 (PubMed) · PMC4013200 (PubMed Central)
  5. Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD. Inamoto Y, Jagasia M, Wood WA, Pidala J, Palmer J, Khera N, Weisdorf D, Carpenter PA, Flowers ME, Jacobsohn D, Martin PJ, Lee SJ, Pavletic SZ, Chronic GVHD Consortium (2014) Bone Marrow Transplant 49(4): 532-8
    › Primary publication · 24464142 (PubMed) · PMC3975688 (PubMed Central)
  6. Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease. Palmer J, Williams K, Inamoto Y, Chai X, Martin PJ, Tomas LS, Cutler C, Weisdorf D, Kurland BF, Carpenter PA, Pidala J, Pavletic SZ, Wood W, Jacobsohn D, Arai S, Arora M, Jagasia M, Vogelsang GB, Lee SJ (2014) Biol Blood Marrow Transplant 20(3): 337-44
    › Primary publication · 24315845 (PubMed) · PMC3973401 (PubMed Central)
  7. Joint and fascia manifestations in chronic graft-versus-host disease and their assessment. Inamoto Y, Pidala J, Chai X, Kurland BF, Weisdorf D, Flowers ME, Palmer J, Arai S, Jacobsohn D, Cutler C, Jagasia M, Goldberg JD, Martin PJ, Pavletic SZ, Vogelsang GB, Lee SJ, Carpenter PA, on behalf of the Chronic GVHD Consortium (2013) Arthritis Rheum
    › Primary publication · 24285254 (PubMed)
  8. Chronic Myelogenous Leukemia, Version 1.2014. O'Brien S, Radich JP, Abboud CN, Akhtari M, Altman JK, Berman E, DeAngelo DJ, Deininger M, Devine S, Fathi AT, Gotlib J, Jagasia M, Kropf P, Moore JO, Pallera A, Pinilla-Ibarz J, Reddy VV, Shah NP, Smith BD, Snyder DS, Wetzler M, Gregory K, Sundar H, Ntational comprehensive cancer network (2013) J Natl Compr Canc Netw 11(11): 1327-40
    › Primary publication · 24225967 (PubMed) · PMC4234105 (PubMed Central)
  9. Geographic distance is not associated with inferior outcome when using long-term transplant clinic strategy. Ragon BK, Clifton C, Chen H, Savani BN, Engelhardt BG, Kassim AA, Vaughan LA, Lucid C, Jagasia M (2014) Biol Blood Marrow Transplant 20(1): 53-7
    › Primary publication · 24120525 (PubMed)
  10. Six-month freedom from treatment failure is an important end point for acute GVHD clinical trials. Sengsayadeth S, Savani BN, Jagasia M, Goodman S, Greer JP, Chen H, Chinratanalab W, Kassim AA, Engelhardt BG (2014) Bone Marrow Transplant 49(2): 236-40
    › Primary publication · 24096824 (PubMed) · PMC3946331 (PubMed Central)
  11. Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma. Reddy NM, Oluwole O, Greer JP, Engelhardt BG, Jagasia MH, Savani BN (2014) Exp Hematol 42(1): 39-45
    › Primary publication · 24096123 (PubMed) · PMC5002948 (PubMed Central)
  12. Comorbidity burden in patients with chronic GVHD. Wood WA, Chai X, Weisdorf D, Martin PJ, Cutler C, Inamoto Y, Wolff D, Pavletic SZ, Pidala J, Palmer JM, Arora M, Arai S, Jagasia M, Storer B, Lee SJ, Mitchell S (2013) Bone Marrow Transplant 48(11): 1429-36
    › Primary publication · 23665819 (PubMed) · PMC3937964 (PubMed Central)
  13. Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium. Pidala J, Chai X, Martin P, Inamoto Y, Cutler C, Palmer J, Weisdorf D, Pavletic S, Arora M, Jagasia M, Jacobsohn D, Lee SJ (2013) Biol Blood Marrow Transplant 19(6): 967-72
    › Primary publication · 23542686 (PubMed) · PMC3966477 (PubMed Central)
  14. Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study. Pidala J, Chai X, Kurland BF, Inamoto Y, Flowers ME, Palmer J, Khera N, Jagasia M, Cutler C, Arora M, Vogelsang G, Lee SJ (2013) Biol Blood Marrow Transplant 19(5): 784-91
    › Primary publication · 23395601 (PubMed) · PMC3896215 (PubMed Central)
  15. Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium. Treister N, Chai X, Kurland B, Pavletic S, Weisdorf D, Pidala J, Palmer J, Martin P, Inamoto Y, Arora M, Flowers M, Jacobsohn D, Jagasia M, Arai S, Lee SJ, Cutler C (2013) Bone Marrow Transplant 48(8): 1123-8
    › Primary publication · 23353804 (PubMed) · PMC3971477 (PubMed Central)
  16. Impact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study. Arora M, Pidala J, Cutler CS, Chai X, Kurland B, Jacobsohn DA, Pavletic SZ, Palmer J, Vogelsang G, Jagasia M, Schultz K, Lee SJ (2013) Leukemia 27(5): 1196-201
    › Primary publication · 23047477 (PubMed) · PMC3942496 (PubMed Central)